Drugdesigntech develops innovative computational solutions to support drug discovery, with a focus on knowledge management and decision support for both biologic therapeutics and small molecule drug discovery.
The company was founded in 2007 by Cédric Merlot and is based in Geneva, Switzerland. The technical expertise has been gathered from biologists and chemists working within the pharmaceutical industry who have a passion for drug discovery and informatics.
This deep understanding of the needs for protein, antibodies and small molecule drug design and discovery has resulted in a new suite of software capable of handling all aspects of drug discovery.
A bridge between bioinformatics and chemoinformatics
Combining the worlds of bioinformatics and cheminformatics, we offer computational solutions that allow in-context decision support for the discovery of therapeutics. Our experience in large pharma and biotechs makes that we understand easily the needs and the individual languages used in each area of the discovery process (biology, protein engineering, screening, chemistry, pharmacology); our passion for informatics allows us to deliver state-of-the-art technical solutions and easy-to-use interfaces.
Expertise in scientific data warehousing
Thanks to an extensive practical experience in data management for drug discovery, Drugdesigntech has successfully implemented several large and medium scale data warehouse. We understand exactly what it takes to provide you with all your data entry and data capture needs. Our data warehouse solution Biocorpora offer a secure, scalable, easy manageable infrastructure to deep analytics or data mining capabilities and robust reporting combined with a true ease of use.
Senior Staff Profile
Cédric Merlot is the CEO of Drugdesigntech which he founded in 2007. After receiving an MSc in Chemistry, he started his career at Sanofi in the molecular modelling group. In 2001 he joined Merck-Serono and had increasing responsibilities in the scientific computing department, with a focus on data management for small molecules and biologicals and computer-assisted drug design for small molecules.
Cédric has a deep expertise in IT, software and algorithm development, and more than 20 years of experience in databases and predictions applied to drug discovery (small molecules, antibodies and other biological entities).